MedTrace Logo

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

NCT00519636 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2016-12-09

Study results available
· View outcomes & findings →

Summary

The purpose of this replicate study to FFU105924 is to provide data on subject preference of FFNS as compared with FPNS.

Conditions

  • Rhinitis, Allergic, Perennial

Interventions

DRUG

FPNS

fluticasone propionate nasal spray

DRUG

FFNS

fluticasone furoate nasal spray

DRUG

placebo FFNS

placebo nasal spray matching fluticasone furoate nasal spray

DRUG

placebo FPNS

placebo nasal spray matching fluticasone propionate nasal spray

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2007-11-30
Completion
2007-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00519636 on ClinicalTrials.gov